Summary
Positive inotropic responses to dobutamine have been examined using isolated myocardium from guinea pigs und humans. The potency (EC50) of dobutamine was 1.5 × 10−6 mol/l on guinea pig papillary muscles, 1.8 × 10−6 mol/l on guinea pig left atria and 2.5 × 10−6 mol/l on human papillary muscle strips. In guinea pig cardiac muscles, Schild plots for the β1-selective antagonist, 1-practolol, using dobutamine as agonist, had slopes of less than unity. This suggested the involvement of other receptors in the inotropic response to dobutamine. The β2-selective antagonist, ICI 118,551, but not the α1-selective antagonist, prazosin, attenuated the dobutamine response in guinea pig papillary muscles. Both ICI 118,551 and prazosin shifted the dobutamine concentration-response curve in guinea pig left atria. The positive inotropic response to dobutamine in human papillary muscles was antagonised by 1-practolol and ICI 118,551 but not by prazosin. The maximal inotropic response to dobutamine was 90% that of calcium measured in the same guinea pig papillary muscles but only 37% that of calcium in human papillary muscle strips. This reduced maximal effect of dobutamine in human myocardium is probably a disease-induced change but species variations cannot be excluded.
Similar content being viewed by others
References
Baumann G, Riess G, Erhardt WD, Felix SB, Ludwig L, Blümel G, Blömer H (1981) Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: Reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors. Am Heart J 101:569–581
Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307:205–211
Bristow MR, Kantrowitz NE, Ginsburg R, Fowler MB (1985) β-Adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol 17 (Suppl 2):41–52
Brodde O-E (1982) Vascular dopamine receptors: demonstration and characterization by in vitro studies. Life Sci 31:289–306
Brown L, Erdmann E (1985) Concentration-response curves of positive inotropic agents before and after ouabain pretreatment. Cardiovasc Res 19:288–298
Brown L, Lorenz B, Erdmann E (1985) The inotropic effects of dopamine and its precursor levodopa on isolated human ventricular myocardium. Klin Wochenschr 63:1117–1123
Brown L, Lorenz B, Erdmann E (1986a) The positive inotropic effects of dopamine and dobutamine in isolated, contracting, diseased human and normal guinea pig ventricular myocardium. J Mol Cell Cardiol 18 (Suppl 1):306
Brown L, Lorenz B, Erdmann E (1986b) Reduced positive inotropic effects in diseased human ventricular myocardium. Cardiovasc Res 20:516–520
Brückner R, Meyer W, Mügge A, Schmitz W, Scholz H (1984) α-Adrenoceptor-mediated positive inotropic effect of phenylephrine in isolated human ventricular myocardium. Eur J Pharmacol 99: 345–347
Francis GS, Goldsmith SR, Cohn JN (1982) Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J 104:725–731
Ginsburg R, Bristow MR, Billingham ME, Stinson EB, Schroeder JS, Harrison DC (1983) Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenol. Circulation 71:1023–1028
Goldberg LL, Glock D, Kohle JD, Barnett A (1984) Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390. Hypertension 6 (Suppl 1):25–30
Kenakin TP (1981) An in vitro quantitative analysis of the alpha adrenoceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity. J Pharmacol Exp Ther 216:210–219
Kenakin TP, Johnson SF (1985) The importance of the α-adrenoceptor agonist activity of dobutamine to inotropic selectivity in the anaesthetized cat. Eur J Pharmacol 111:347–354
Leier CV, Unverferth DV (1983) Dobutamine. Ann Int Med 99:490–496
Mügge A, Posselt D, Reimer U, Schmitz W, Scholz H (1985) Effects of the beta2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium. Klin Wochenschr 63:26–31
Newman WH, Webb JG (1980) A differential inotropic responsiveness to isoprenaline and ouabain in dogs with heart failure. Cardiovasc Res 14:530–536
Ruffolo RR Jr, Spradlin TA, Pollock GD, Waddell JD, Murphy PJ (1981) Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 219:447–452
Ruffolo RR Jr, Yaden EL (1983) Vascular effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 224:46–50
Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41:233–243
Wagner J, Schümann HJ, Knorr A, Rohm N, Reidemeister JC (1980) Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial α-adrenoceptors mediating positive inotropic effects in human atrial preparations. Naunyn-Schmiedeberg's Arch Pharmacol 312:99–102
Zerkowski H-R, Ikezono K, Rohm N, Reidemeister JC, Brodde OE (1986) Human myocardial β-adrenoceptors: demonstration of both β1- and β2-adrenoceptors mediating contractile responses to β-agonists on the isolated right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 332:142–147
Author information
Authors and Affiliations
Additional information
Send offprint requests to E. Erdmann at the above address
These studies were supported by the Deutsche Forschungsgemeinschaft (Er 65/4-4). Part of these studies was presented at the XII Congress of the International Society for Heart Research in Melbourne, Australia, February 1986 (Brown et al. 1986a)
Rights and permissions
About this article
Cite this article
Brown, L., Näbauer, M. & Erdmann, E. Dobutamine: positive inotropy by nonselective adrenoceptor agonism in isolated guinea pig and human myocardium. Naunyn-Schmiedeberg's Arch Pharmacol 335, 385–390 (1987). https://doi.org/10.1007/BF00165552
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00165552